Dr. Adam D. Klotz, MD

Dr. Klotz practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Klotz's NPI, 1952373300, was assigned on February 1, 2006. Dr. Klotz graduated from Icahn School of Medicine at Mount Sinai in 1996. Dr. Klotz holds New York license 208720.

Dr. Klotz's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Klotz's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Klotz to 6 more group practices and clinics and 6 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klotz practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Klotz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Klotz is licensed in New York.

CMS data shows 312 Medicare services from Dr. Klotz across 4 procedure codes in 2024, for 323 Medicare patients. Medicare paid $43,309 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 323 Medicare patients who saw Dr. Klotz in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klotz's median patient age at 70, with 47% women.

In 2024, Dr. Klotz wrote 85 Medicare Part D claims for 55 patients. 91% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $97 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Klotz for performance year 2024, reported as part of a group. Dr. Klotz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Klotz, published from 2015 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Emergency Service, Hospital, Emergency Medical Services and Medical Oncology. Dr. Klotz's most frequent co-authors are Christopher William Baugh, MBA, MD, Daniel Jonathan Henning, MD and Gary Herbert Lyman, MD.

CMS Open Payments shows 1 general payment to Dr. Klotz from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. GE Healthcare paid the most, $244.

Dr. Klotz graduated from Icahn School of Medicine at Mount Sinai in 1996.